Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

nature’s best europe s.a. - kapsula

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenēma nātrijs - bakteriālas infekcijas - ertapenēms - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 un 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 un 5.

Latvija - latviešu - Zāļu valsts aģentūra

g.l. pharma gmbh, austria - thiamini hydrochloridum, pyridoxini hydrochloridum, cyanocobalaminum - apvalkotā tablete

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

aconitum uab - kapsula

Latvija - latviešu - Zāļu valsts aģentūra

g.l. pharma gmbh, austria - cyanocobalaminum, pyridoxini hydrochloridum, thiamini hydrochloridum - apvalkotā tablete

Latvija - latviešu - Zāļu valsts aģentūra

pfizer spol. s.r.o., czech republic - gabapentīns - kapsula, cietā - 400 mg

Latvija - latviešu - Zāļu valsts aģentūra

pfizer hellas a.e., greece - gabapentīns - kapsula, cietā - 400 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

roche registration gmbh - satralizumab - neuromyelitis optica - imūnsupresanti - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - imūnsupresanti - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.